网易首页 > 网易号 > 正文 申请入驻

【维•关注】从海德堡讲台到浙江丽水主场:一家中国医院的国际化样板

0
分享至

以介入医学为支点,以院士机制与学术平台为杠杆,温州医科大学附属第五医院(丽水市中心医院)正把临床一线的经验,沉淀为可以与世界共享的中国方案。

双城之间:一场学术对话的两个会场

2026年11月,一场关于医学与工程的对话,在两个会场同时展开。第三届中欧科学家论坛在德国法兰克福举行,200 余位来自中国、德国、法国、英国等国的科学家、院士及产业界代表与会;几乎同一时间,11 月 6 日至 7 日,论坛旗下的第二届中欧科学家专场落地中国浙江丽水,是 2026 年浙江省医学会介入医学学术大会三大国际专场之一。


会议期间,欧洲科学院医学工程学部主任、意大利都灵理工大学 Giuseppe Lacidogna 院士专程到场,将“中欧科学家论坛卓越成就奖”授予丽水市中心医院党委书记纪建松教授,以及欧洲科学院院士、米兰理工大学 Hamid Reza Karimi 院士。


丽水与这一欧洲学术平台的往来,始于一年前。2025 年 11 月 1 日,德国海德堡,第二届中欧科学家论坛主论坛上,纪建松教授团队受邀登台,报告自主研发的可降解镁微球肝癌栓塞治疗(M-TACE)成果;一个多月后,12 月 5 日至 6 日,论坛的首届介入医学平行论坛在杭州举办,主办方正是该院。先是被请上主论坛的讲台,继而是承办平行论坛,一家来自中国浙西南的医院,在中欧医学学术对话中的位置,由此渐渐清晰。

海德堡讲台上的原创成果:从实验室到临床

中欧科学家论坛由 30 余位来自德国、法国、荷兰、瑞士、丹麦、芬兰、意大利、西班牙等国的知名科学家于 2023 年 12 月共同发起,70 余家以德国、法国为主的科学协会和机构参与共建,是在欧洲正式注册的非营利组织。在第二届中欧科学家论坛主论坛上,丽水市中心医院党委书记、介入医学专家纪建松教授团队受邀发表题为“影像与介入医学研究:从实验室到临床”的主题演讲。受团队委派,团队青年骨干代表登台,向欧洲同行展示了团队自主研发、用于中晚期肝癌栓塞治疗的可降解镁微球(M-TACE)研究成果。临床数据显示入组肝癌患者安全性和耐受性良好,客观缓解率达 93.3%,显著高于当前常规 TACE 治疗的响应率,相关研究成果发表于国际权威期刊 Science Advances杂志。目前,M-TACE 疗法已进入全国多中心随机对照注册临床研究阶段 , 由中国科学院院士滕皋军教授与纪建松教授共同担任项目负责人(PI),以丽水市中心医院为牵头单位组织实施。

连续两年承办平行论坛:从参与者到组织者

海德堡主论坛上形成的合作共识,很快落到了杭州。2025 年 12 月,“介入医学工程与生物技术国际论坛”暨 2025 中欧科学家论坛介入医学平行论坛在杭州召开,由丽水市中心医院主办。中欧科学家论坛轮值主席、欧洲科学院院士、意大利米兰理工大学 Hamid Reza Karimi 院士,全欧华人专业协会联合会执行主席周盛宗教授等出席。会上,纪建松教授与Karimi 院士、加拿大工程院院士 Simon X. Yang 教授一同获颁“ 中欧科学家论坛杰出成就奖”。


一年后,这一机制性合作延伸至丽水。2026 年 11 月 6 日至 7 日举办的第二届中欧科学家专场,议题从荧光分子成像、人本医疗机器人,延伸至介入脑机接口的长效安全、低维半导体触觉仿生器件等交叉前沿领域。Lacidogna 院士在颁奖时提到,纪建松教授“扎根临床一线,深耕介入医学与医工融合创新,聚焦肿瘤介入诊疗技术攻关与成果转化”,其牵头承办的平行论坛“有力推动中欧临床医学的交流互鉴”。

院士领衔:平台、共识与梯队

丽水市中心医院在介入领域的跃升,与中国介入放射学领军人物滕皋军院士的深度合作密不可分。滕皋军是中国医学影像与介入放射领域的首位中国科学院院士(2021年当选),他从事介入医学临床工作 40 余年,三度获得国家科技进步奖二等奖,发表论文 500 余篇,授权国内外发明专利 30 余项,并先后获美国、欧洲及亚太三大主流介入学会最高荣誉奖。

滕皋军院士受聘为温州医科大学影像诊断与介入微创研究所首席科学家,并与丽水市中心医院博士后工作站签订院士博士后导师联合培养协议。此后,合作由平台共建走向纵深:滕皋军院士担任浙江省影像与介入医学重点实验室名誉主任,与实验室主任纪建松教授形成“院士领衔、团队承接”的稳定协作机制;2026年9月,滕皋军院士专程赴丽水市中心医院介入诊疗中心开展公益坐诊,把国家级诊疗资源送到了浙西南患者身边。

真正说明合作深度的,是随之而来的成果。在滕皋军院士的引领和指导下,该院接连发布《支气管动脉栓塞治疗咯血专家共识》与《经动脉化疗栓塞联合消融治疗肝细胞癌专家共识》两部全国性专家共识,后者填补了经动脉化疗栓塞(TACE)联合消融治疗领域统一共识的空白;M-TACE 全国多中心注册临床研究,则以“院士与区域医院学科带头人共同担任联合PI”的规格,将丽水推到了肝癌介入创新疗法临床转化的前沿。



牵头承接这一系列合作的纪建松教授,本身即全国先进工作者、国家重点研发计划首席科学家。由其牵头的“十四五”国家重点研发计划项目,联合了浙江大学、清华大学、南方科技大学等多所高校共同攻关;已连续五年入选全球前 2%顶尖科学家榜单,并受聘意大利博洛尼亚大学医学院客座教授。

一份多年未断的“出勤表”

请进来与走出去,节奏同样频密。该院已连续三届牵头举办中美影像与介入高峰论坛,并主办中德医师年会,首届年会即有9名德国顶尖医疗专家与逾千名国内学者参会。人才外派也在稳步加密:长期选派学科骨干赴德国、瑞士、奥地利、美国、意大利等国一流机构研修;近三年累计选派 52 名医护人员赴意大利、西班牙、匈牙利等 12 个国家研修深造;按该院“13350”人才工程规划,未来几年还将选派 100 名以上优秀青年人才赴国外高水平机构深造。这种双向流动并不喧哗,却构成了丽水市中心医院国际化路径中最具延续性的部分:人被送出去,视野被带回来,学科才真正有了接续的可能。


侨乡为原点:全球协作网络与中国医疗服务

丽水是著名的侨乡,有 47.3 万华侨华人旅居海外 160 多个国家。丽水市中心医院的国际化路径,带着鲜明的侨乡印记,却远不止于乡情。

瑞典卡罗林斯卡医学院与丽水市中心医院的往来,为观察这一网络提供了具体坐标。作为诺贝尔生理学或医学奖评选机构,卡罗林斯卡医学院与该院互动频密:

2023 年 7 月,瑞典皇家卡罗林斯卡大学医院耳鼻喉头颈外科主任医师段茂利教授受邀来院讲学;其后,中国工程院外籍院士、瑞典卡罗林斯卡医学院终身教授、世界公认的血管新生领域顶尖科学家曹义海院士亦专程来院作学术指导,围绕新生血管与肿瘤、心血管疾病等前沿方向开设专题讲座。


从瑞典到意大利、西班牙、匈牙利,再到塞尔维亚,医院的欧洲合作沿着高水平机构之间的稳定往来展开,高频次、高规格的机构间互动渐成常态。该院与意大利博洛尼亚大学医学院及其附属弗利医院的合作已进入常态化阶段。2024 年 5 月,医院专家团队专程赴博洛尼亚大学医学院及附属弗利医院发表演讲,纪建松教授获聘博洛尼亚大学医学院客座教授;与西班牙巴塞罗那海滨医院、西班牙 Quirónsalud医疗集团等机构签约合作;匈牙利分院签约落地,与塞尔维亚、尼加拉瓜的合作稳步推进。一张以丽水为原点、辐射全球的“国际医联体服务网络”正在成形。







为侨服务的体系化布局同步加速。据院方最新统计,截至目前,医院已与全球42 家海外侨团及机构签订健康保障合作协议,覆盖欧洲、南美等多地浙籍侨胞聚居区;2026 年以来,先后与巴西中国浙江商会、捷克青田同乡会、欧洲华侨华人青年联合总会等侨团缔结“健康盟约”。2026 年 7 月 19 日,该院举办国际化医疗服务高质量发展大会,正式发布“国际医疗健康事业3.0战略”,上线一站式华侨线上服务平台“侨e心”小程序,并设立海外侨胞健康保障联络中心。该院国际健康管理中心,近三年已累计接待服务华侨 4.9 万余人次;2025 年,海外华人华侨来院就诊即超过一万人次。

临床与服务的网络之外,科研积累构成了另一重支撑。该院拥有全国唯一的介入医学博士点,2024 年入选浙江省首批研究型医院培育单位,并在首年评估中位列培育医院第一;近三年,医院获国家重点研发计划、国家自然科学基金区域联合重点等国家级项目 13 项,省尖兵领雁项目等省部级项目28项。共发表论文 600余篇 , 其中 SCI 论文 300 余篇;获发明专利 6 件,实用新型专利 38 件,计算机软件著作权 53 件。

观察:区域医院的“第三种国际化”

在中国医疗版图上,高能级科研平台与国际学术话语权,长期集中在国家医学中心与沿海大型医院。丽水既非省会,也不拥有医学院校总部资源;论区位、论体量,这里似乎都不具备参与国际学术竞争的先发条件。

然而丽水市中心医院提供了另一种路径:以一门优势学科——介入医学为支点,以院士合作与高能级平台(国家级博士后科研工作站、省级院士工作站、浙江省影像与介入医学重点实验室等)为杠杆,再以侨乡网络与中欧学术平台为通道,把临床遇到的具体问题转换成国际学术对话的公共议题。对一家不具备区位与资源加持的医院而言,27 项成果亮相欧洲放射学大会、连续两年承办中欧科学家论坛平行论坛、在介入材料源头创新上牵头全国多中心注册临床研究——这些事情的难度与成色,远比单纯的指标堆砌更值得细看。

更深一层的变化,发生在输出的形态上。从单项技术成果的发布,到学术平台的承办、行业共识的制定、人才网络的双向流动,再到面向海外侨胞的体系化医疗服务,该院完成的,是由“技术输出”向“经验与方案输出”的过渡。前者给出的是产品,后者给出的是方法、标准与组织方式;前者可以被复制,后者才可能被引用。这条路是否可复制,尚待时间检验,但其启示已经清晰:在全球医学创新网络中,决定一家医院位置的,未必是它所在城市的经纬度,而是它是否愿意把一处临床难题,当作一个可以向世界提问的题目。

From a Heidelberg Podium to a Home Stage in Lishui, Zhejiang: The Internationalization Template of a Chinese Hospital

Leveraging interventional medicine as its foundation and the academicians mechanism and academic platforms as strategic drivers, the Fifth Affiliated Hospital of Wenzhou Medical University (Lishui Municipal Central Hospital) is distilling frontline clinical experience into Chinese solutions that can be shared with the world.

Between Two Cities: Two Venues of One Academic Dialogue

In November 2026, a dialogue on medicine and engineering unfolded simultaneously at two venues. The Third China-Europe Scientists Forum was held in Frankfurt, Germany, bringing together more than 200 scientists, academicians and industry representatives from China, Germany, France, the United Kingdom and other countries; almost at the same time, on November 6–7, the Second China-Europe Scientists Special Session under the Forum was held in Lishui, Zhejiang, China, as one of the three international special sessions of the 2026 Zhejiang Medical Association Interventional Medicine Academic Conference.

During the conference, Academician Giuseppe Lacidogna, Director of the Medical Engineering Division of the European Academy of Sciences and professor at Politecnico di Torino, Italy, made a special trip to the venue to present the "China-Europe Scientists Forum Outstanding Achievement Award" to Professor Ji Jiansong, President of Lishui Municipal Central Hospital, and Academician Hamid Reza Karimi of Politecnico di Milano, an academician of the European Academy of Sciences.

Lishui’s engagement with this European academic platform began a year ago. On November 1, 2025, at the main forum of the Second China-Europe Scientists Forum in Heidelberg, Germany, Professor Ji Jiansong’s team was invited to present its research on transarterial chemoembolization for hepatocellular carcinoma using independently developed biodegradable magnesium microspheres (M-TACE). Just over a month later, on December 5–6, the inaugural parallel session on interventional medicine under the forum was held in Hangzhou, with the hospital serving as its organizer.

From being invited to present at the main forum to hosting a dedicated parallel session, the role of a hospital from southwestern Zhejiang, China, in China-Europe academic dialogue in medicine has gradually come into focus.

Original Achievements on the Heidelberg Podium: From Laboratory to Clinic

The China-Europe Scientists Forum was jointly initiated in December 2023 by more than 30 renowned scientists from Germany, France, the Netherlands, Switzerland, Denmark, Finland, Italy, Spain and other countries, with more than 70 scientific associations and institutions, mainly from Germany and France, participating in its co-construction; it is a non-profit organization formally registered in Europe. At the main forum of the Second China-Europe Scientists Forum, Professor Ji Jiansong, President of Lishui Municipal Central Hospital and an interventional medicine expert, and his team were invited to deliver a keynote speech titled "Imaging and Interventional Medicine Research: From Laboratory to Clinic." Delegated by the team, a young core member took the podium to present to European peers the team's self-developed degradable magnesium microspheres (M-TACE) for embolization therapy of intermediate-to-advanced liver cancer. Clinical data showed that enrolled liver cancer patients had good safety and tolerability, with an objective response rate of 93.3%, significantly higher than the response rate of current conventional TACE treatment; the related research findings were published in the internationally authoritative journal *Science Advances*. Currently, M-TACE therapy has entered the stage of a nationwide multicenter randomized controlled registered clinical study, with Academician Teng Gaojun of the Chinese Academy of Sciences and Professor Ji Jiansong serving jointly as project leaders (PI), and Lishui Municipal Central Hospital as the lead institution organizing its implementation.

Hosting the Parallel Forum for Two Consecutive Years: From Participant to Organizer

The cooperation consensus formed at the Heidelberg main forum quickly landed in Hangzhou. In December 2025, the "International Forum on Interventional Medical Engineering and Biotechnology" and the 2025 China-Europe Scientists Forum Interventional Medicine Parallel Forum were held in Hangzhou, hosted by Lishui Municipal Central Hospital. Academician Hamid Reza Karimi of Politecnico di Milano, Italy, Rotating Chair of the China-Europe Scientists Forum and academician of the European Academy of Sciences, Professor Zhou Shengzong, Executive Chairman of the Federation of Chinese Professional Associations in Europe, and others attended. At the meeting, Professor Ji Jiansong, Academician Karimi and Professor Simon X. Yang, academician of the Canadian Academy of Engineering, were jointly awarded the "China-Europe Scientists Forum Outstanding Achievement Award."

A year later, this institutional collaboration took a further step by extending to Lishui. Held on November 6–7, 2026, the Second China-Europe Scientists Special Session covered a wide range of topics, from fluorescence molecular imaging and human-centered medical robotics to the long-term safety of interventional brain-computer interfaces and low-dimensional semiconductor-based tactile bionic devices, bringing together expertise from diverse cutting-edge fields.

During the award ceremony, Academician Lacidogna highlighted Professor Ji Jiansong’s contributions, noting that he “has remained firmly grounded in frontline clinical practice, pursued innovation at the intersection of interventional medicine and medical engineering, and focused on advancing key technologies and translating research into clinical applications in interventional oncology.” He also recognized that the parallel forum organized under Professor Ji’s leadership had “effectively promoted academic exchange and mutual learning between Chinese and European clinical medicine communities.”

Academician Leadership: Platforms, Consensus and Talent Pipelines

The leap of Lishui Municipal Central Hospital in the interventional field is inseparable from its deep cooperation with Academician Teng Gaojun, a leading figure in Chinese interventional radiology. Teng Gaojun is the first Academician of the Chinese Academy of Sciences in the field of Chinese medical imaging and interventional radiology (elected in 2021). He is currently Director of the Medical and Life Sciences Division of Southeast University, Director of the Interventional Treatment Center of Zhongda Hospital Affiliated to Southeast University, and concurrently Director of the Medical Basic Research Innovation Center of the Ministry of Education, Head of the National Medical Key Research Integration of Industry and Education Innovation Platform, Director of the National Comprehensive Interventional Technology Quality Control Center, President of the Interventional Physicians Branch of the Chinese Medical Doctor Association, Founding President of the International Society of Multidisciplinary Interventional Oncology (ISMIO), and former President of the Asia-Pacific Society of Cardiovascular and Interventional Radiology (APSCVIR). He has been engaged in clinical work in interventional medicine for more than 40 years, has won the Second Prize of the National Science and Technology Progress Award three times, published more than 500 papers, been authorized more than 30 domestic and foreign invention patents, and has successively received the highest honors from the three major mainstream interventional societies in the United States, Europe and the Asia-Pacific region.

Academician Teng Gaojun was appointed Chief Scientist of the Institute of Imaging Diagnosis and Interventional Minimally Invasive Research of Wenzhou Medical University, and signed an academician postdoctoral supervisor joint training agreement with the postdoctoral workstation of Lishui Municipal Central Hospital. Since then, cooperation has moved from platform co-construction to deeper levels: Academician Teng Gaojun serves as Honorary Director of the Zhejiang Provincial Key Laboratory of Imaging and Interventional Medicine, forming a stable collaboration mechanism of "academician leadership and team undertaking" with Laboratory Director Professor Ji Jiansong; in September 2026, Academician Teng Gaojun made a special trip to the Interventional Diagnosis and Treatment Center of Lishui Municipal Central Hospital to conduct a public welfare consultation, bringing national-level diagnostic and treatment resources to patients in southwestern Zhejiang.

What truly demonstrates the depth of cooperation is the achievements that followed. Under the guidance and leadership of Academician Teng Gaojun, the hospital successively released two national expert consensus documents: the Expert Consensus on Bronchial Artery Embolization for Hemoptysis and the Expert Consensus on Transarterial Chemoembolization Combined with Ablation for Hepatocellular Carcinoma, the latter filling the gap of unified consensus in the field of transarterial chemoembolization (TACE) combined with ablation therapy; the M-TACE nationwide multicenter registered clinical study, with the specification of "academician and regional hospital discipline leader jointly serving as co-PI," pushed Lishui to the forefront of clinical translation of innovative interventional therapies for liver cancer.

Professor Ji Jiansong, who led and undertook this series of cooperation, is himself a National Advanced Worker and Chief Scientist of a National Key R&D Program. The "14th Five-Year Plan" National Key R&D Program project he led jointly tackles key problems with Zhejiang University, Tsinghua University, Southern University of Science and Technology and other universities; he has been selected for the list of the world's top 2% scientists for five consecutive years and has been appointed Visiting Professor at the School of Medicine of the University of Bologna, Italy.

A Longstanding Record of International Academic Engagement

The hospital’s international exchanges have maintained a steady rhythm, both in welcoming experts from abroad and sending its own professionals overseas. It has taken the lead in organizing three consecutive editions of the China-US Summit Forum on Medical Imaging and Interventional Medicine, and hosted the China-Germany Annual Conference for Physicians. The inaugural conference alone brought together nine leading German medical experts and more than 1,000 Chinese scholars.

The hospital has also steadily expanded its international talent development programs. It regularly sends key academic and clinical staff to leading institutions in Germany, Switzerland, Austria, the United States, Italy and other countries for advanced training. Over the past three years, a total of 52 medical professionals have been selected for training and professional development programs across 12 countries, including Italy, Spain and Hungary. Under its “13350” Talent Development Program, the hospital plans to send more than 100 outstanding young professionals to leading overseas institutions for further training over the coming years.

This two-way exchange may not command the spotlight, but it represents one of the most enduring elements of Lishui Municipal Central Hospital’s internationalization strategy: professionals go abroad, broader perspectives return home, and the foundations are laid for sustained academic development and the continuity of clinical disciplines.

The Hometown of Overseas Chinese as the Origin: A Global Collaboration Network and Chinese Medical Services

Lishui is a famous hometown of overseas Chinese, with 473,000 Chinese nationals and people of Chinese origin residing in more than 160 countries. The internationalization path of Lishui Municipal Central Hospital bears a distinct imprint of the hometown of overseas Chinese, yet it goes far beyond nostalgia.

The exchanges between Karolinska Institutet in Sweden and Lishui Municipal Central Hospital provide concrete coordinates for observing this network. As the institution that selects the Nobel Prize in Physiology or Medicine, Karolinska Institutet interacts frequently with the hospital: in July 2023, Professor Duan Maoli, Chief Physician of the Department of Otorhinolaryngology, Head and Neck Surgery at Karolinska University Hospital, Sweden, was invited to lecture at the hospital; thereafter, Academician Cao Yihai, Foreign Academician of the Chinese Academy of Engineering, tenured professor at Karolinska Institutet, Sweden, and a world-renowned top scientist in the field of angiogenesis, also made a special trip to the hospital for academic guidance, giving special lectures on frontier directions such as angiogenesis and tumors and cardiovascular diseases.

From Sweden to Italy, Spain, Hungary and then Serbia, the hospital's European cooperation unfolds along stable exchanges between high-level institutions, and high-frequency, high-standard inter-institutional interactions are gradually becoming the norm. Cooperation between the hospital and the School of Medicine of the University of Bologna, Italy, and its affiliated Forlì Hospital has entered a normalized stage. In May 2024, the hospital's expert team made a special trip to the School of Medicine of the University of Bologna and the affiliated Forlì Hospital to give lectures, and Professor Ji Jiansong was appointed Visiting Professor at the School of Medicine of the University of Bologna; agreements were signed for cooperation with Hospital del Mar in Barcelona, Spain, and the Quirónsalud medical group in Spain; the Hungarian branch was signed and established, and cooperation with Serbia and Nicaragua is steadily advancing. An "international medical consortium service network" with Lishui as its origin and radiating globally is taking shape.

The systematic layout of services for overseas Chinese is accelerating simultaneously. According to the latest statistics of the hospital, as of now, the hospital has signed health protection cooperation agreements with 42 overseas Chinese associations and institutions worldwide, covering areas where Zhejiang-born overseas Chinese are concentrated in Europe, South America and other regions; since 2026, it has successively concluded "health covenants" with the Brazil China Zhejiang Chamber of Commerce, the Czech Qingtian Native Place Association, the European Federation of Young Chinese Professionals and other overseas Chinese associations. On July 19, 2026, the hospital held the Conference on High-Quality Development of International Medical Services, officially releasing the "International Medical and Health Undertaking 3.0 Strategy," launching the one-stop online service platform for overseas Chinese, the "Qiao e Xin" mini-program, and establishing the Overseas Chinese Health Protection Liaison Center. The hospital's International Health Management Center has, in the past three years, received and served more than 49,000 visits by overseas Chinese; in 2025 alone, more than 10,000 visits were made by overseas Chinese.

Beyond the clinical and service network, scientific research accumulation constitutes another support. The hospital has the only doctoral program in interventional medicine in the country, was selected in 2024 as one of the first batch of research-oriented hospital cultivation units in Zhejiang Province, and ranked first among cultivation hospitals in the first-year evaluation; in the past three years, the hospital has obtained 13 national-level projects including National Key R&D Programs and National Natural Science Foundation Regional Joint Key Projects, and 28 provincial and ministerial-level projects such as Zhejiang Provincial Pioneer and Leading Goose Projects. It has published more than 600 papers, including more than 300 SCI papers; obtained 6 invention patents, 38 utility model patents, and 53 computer software copyrights.

A Closer Look: The “Third Path” to Internationalization for Regional Hospitals

Across China’s healthcare landscape, high-level research platforms and international academic influence have traditionally been concentrated in national medical centers and major hospitals in coastal metropolitan areas. Lishui is neither a provincial capital nor home to the headquarters of a medical university. In terms of geography and institutional scale, it would appear to lack the advantages typically associated with early participation in international academic competition.

Yet Lishui Municipal Central Hospital offers an alternative pathway. It uses a single area of disciplinary strength—interventional medicine—as its foundation; leverages academician partnerships and high-level research platforms, including a National Postdoctoral Research Workstation, a Provincial Academician Workstation, and the Zhejiang Provincial Key Laboratory of Medical Imaging and Interventional Medicine; and draws on overseas Chinese networks and China-Europe academic platforms as channels for international engagement. Through this approach, specific challenges encountered in clinical practice are transformed into topics of broader international academic dialogue.

For a hospital without the advantages of a prime location or concentrated institutional resources, achievements such as presenting 27 research projects at the European Congress of Radiology, hosting parallel sessions of the China-Europe Scientists Forum for two consecutive years, and leading a nationwide multicenter clinical registration study on innovations at the source of interventional materials deserve closer examination. Their significance and the effort behind them go far beyond the accumulation of performance indicators.

A more profound transformation is taking place in the form of what the hospital brings to the international stage. Moving beyond the publication of individual technological achievements, the hospital has progressed to hosting academic platforms, helping shape industry-wide consensus, fostering two-way talent exchanges, and developing systematic healthcare services for overseas Chinese communities. In doing so, it has made the transition from “technology export” to the sharing of experience and solutions.

The former delivers products; the latter offers methodologies, standards and organizational models. Products can be replicated, but approaches and frameworks are what others can learn from, reference and adopt.

Whether this pathway can be replicated elsewhere remains to be tested over time. Its broader lesson, however, is already clear: within the global medical innovation network, a hospital’s position is not necessarily determined by the geographical coordinates of the city it calls home, but by whether it is willing to turn a clinical challenge encountered locally into a question worth putting to the world.


特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。

Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.

相关推荐
热点推荐
收视率几乎为0,县城电视台为什么还没关?

收视率几乎为0,县城电视台为什么还没关?

罗sir财话
2026-11-15 12:56:18
旭日旗事件越闹越大!陈宇昕三代都是亲日分子,母亲身份已澄清

旭日旗事件越闹越大!陈宇昕三代都是亲日分子,母亲身份已澄清

平老师666
2026-10-27 20:56:19
将黄乐送给黄仁勋的正是其丈夫本人

将黄乐送给黄仁勋的正是其丈夫本人

辇毂
2026-11-12 21:53:52
那张脸,三十年后还能把人摁在沙发上

那张脸,三十年后还能把人摁在沙发上

草莓解说体育
2026-11-20 01:13:51
中国绝不会接受本土遭到攻击后,还陪着你打所谓的 "有限战争"

中国绝不会接受本土遭到攻击后,还陪着你打所谓的 "有限战争"

迷彩人生
2026-11-13 10:25:30
业内不建议买500元以下羽绒服,何不食肉糜?山姆成了众矢之的

业内不建议买500元以下羽绒服,何不食肉糜?山姆成了众矢之的

一拙见
2026-11-15 16:46:04
骑士胜步行者!哈登轰51分主导胜局,3配角齐发挥,米切尔阿伦哑火

骑士胜步行者!哈登轰51分主导胜局,3配角齐发挥,米切尔阿伦哑火

篮球资讯达人
2026-11-21 10:59:51
那些年,APEC峰会领导人们穿过的“花衣裳”

那些年,APEC峰会领导人们穿过的“花衣裳”

黄娜老师
2026-11-20 09:17:10
7胜3负!德国大师赛大爆局:丁俊晖逆转失147,周跃龙0-3逆天翻盘

7胜3负!德国大师赛大爆局:丁俊晖逆转失147,周跃龙0-3逆天翻盘

林子说事
2026-11-21 03:11:20
姚笛分享近况,住大房子连凳子都是LV的,但并不开心焦虑到躯体化

姚笛分享近况,住大房子连凳子都是LV的,但并不开心焦虑到躯体化

八怪娱
2026-11-18 09:29:26
马斯喀特球星挑战赛11月21日直播赛程,陈垣宇迎战户上隼辅

马斯喀特球星挑战赛11月21日直播赛程,陈垣宇迎战户上隼辅

乒乓球球
2026-11-21 08:57:08
加满一箱可能省十几块,但这轮油价下调最该弄清的不是省多少

加满一箱可能省十几块,但这轮油价下调最该弄清的不是省多少

音乐时光的娱乐
2026-11-21 10:08:39
数字领新|2027深圳跨境电商展会定福田

数字领新|2027深圳跨境电商展会定福田

记录展会的王先生
2026-11-20 23:16:22
CBA最新消息!上海男篮或裁掉拉塞尔,浙江广厦留用威尔斯

CBA最新消息!上海男篮或裁掉拉塞尔,浙江广厦留用威尔斯

体坛瞎白话
2026-11-21 11:08:02
零宣发直接爆!播6集播放破亿,这下饭剧太上头

零宣发直接爆!播6集播放破亿,这下饭剧太上头

可乐谈情感
2026-11-21 02:29:18
沈阳新娘远嫁杭州,娘家30口人自驾送亲,新郎只愿付当天住宿费

沈阳新娘远嫁杭州,娘家30口人自驾送亲,新郎只愿付当天住宿费

兰姐说故事
2025-08-21 20:05:04
这微胖女孩的穿搭,胆量比肉感更值得聊

这微胖女孩的穿搭,胆量比肉感更值得聊

记录生活的小明
2026-11-21 06:35:12
钱再多有什么用,65岁郎平如今的现状,给所有运动员们提了个醒

钱再多有什么用,65岁郎平如今的现状,给所有运动员们提了个醒

墨策讲历史
2026-11-04 22:47:01
欧文或重返76人!詹欧连线在线,埃奇库姆赴达拉斯

欧文或重返76人!詹欧连线在线,埃奇库姆赴达拉斯

湖人侃球师
2026-11-21 09:28:46
发射倒计时!神舟二十四传来好消息,已抵达发射区,这次有新任务

发射倒计时!神舟二十四传来好消息,已抵达发射区,这次有新任务

古书奇谈
2026-11-21 08:55:03
2026-11-21 11:28:49
维城 incentive-icons
维城
奥地利最受欢迎的公众号!
15449文章数 40710关注度
往期回顾 全部

健康要闻

医生眼里"很伤腰"的椅子,很多人天天坐

头条要闻

历时14小时特朗普返回美国 刚下飞机就发布"重大预告"

头条要闻

历时14小时特朗普返回美国 刚下飞机就发布"重大预告"

体育要闻

脚步未停!西班牙摩托车手赤脚徒步入境中国

娱乐要闻

官媒发文 官宣赵丽颖新身份,进步很大

财经要闻

最大回撤超37%,黄金崩盘了吗?

科技要闻

老黄想回来?英伟达董事会:没门

汽车要闻

全新红旗H9最有意思的地方,是它开始有自己的豪华逻辑了

态度原创

艺术
亲子
游戏
公开课
军事航空

艺术要闻

投资55亿!深圳歌剧院施工现场更新,主音乐厅马蹄形已现!

亲子要闻

宝宝必看的5个启蒙动画,豆瓣评分都是在9.0以上

PC Gamer试玩GTA6百小时:双主角出色但任务重复

公开课

李玫瑾:为什么性格比能力更重要?

军事要闻

沙特首都第一高楼遭袭:炮弹从天而降

无障碍浏览 进入关怀版